The dose or the medication itself Sometimes it really is this simple: some people respond better to a dual agonist like tirzepatide than to semaglutide, and others simply need more time at a therapeutic dose before the full effect kicks in
dorsal-ventral 2.0 mm from the bregma)
Data on demographics, comorbidities, lab results, imaging, and treatment were abstracted
If you're ready to take the next step in your weight loss journey, contact MOH Clinics today for a personalized consultation
Retrieved from Huseinovic, E., Bertz, F., Leu Agelii, M., et al
GLP-1Ra at doses intended for T2D management Studies have examined the risk of fracture in both obese and non-obese individuals taking GLP-1Ra at doses intended for T2D (such as liraglutide 1.2 mg daily versus 3.0 mg daily for obesity) [75,76,77]